Wednesday, November, 25, 2009

Breast Cancer Home >
SharePosts >
Health Professional >
Kevin Knopf, MD >
Tamoxifen Effectiveness and the CYP2D6 Gene

Font size
- A
- A
- A
Email This

Featured ContentWhat If? Statistics and Public Health

Tamoxifen Breakdown Gene CYP2D6 - Is the Plot Thickening?

Kevin Knopf, MD Health Professional Medical Oncologist Dr. Knopf is currently a medical oncologist in private practice in... Send Message Subscribe: Kevin Knopf, MD

Monday, May 12, 2008
View All of Kevin Knopf, MD's Posts

I wrote about CYP2D6, which refers to a gene that codes for a biologic molecule involved in the breakdown of tamoxifen, about a year ago. Since then it has not become standard of care to order this on patients taking tamoxifen, but my desire to do so has increased. Routine testing is ...

Hide Comments | Add comment

thank you
Adriene Hughes
Wednesday, May 14, 2008 at 01:48 PM

excellent article and will be sure to bring this up with my oncologist as I am a younger woman on Tamoxifen. super helpful.

Font size
- A
- A
- A
Email This

Bookmark
Thank you for your input

Save
RSS
Report Abuse

Ask a Question

Get answers from our experts and community members.

View all questions (3944) >

Related Breast Cancer Topics

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyBreastCancerNetwork.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.